Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOGLIPTIN\METFORMIN vs ALPRAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALOGLIPTIN\METFORMIN vs ALPRAZOLAM: Safety Overview

Metric ALOGLIPTIN\METFORMIN ALPRAZOLAM
Total FAERS Reports 372 48,357
Deaths Reported 27 16,072
Death Rate 7.3% 33.2%
Hospitalizations 143 15,996
Average Patient Age 67.2 yrs 48.1 yrs
% Female Patients 42.0% 60.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Endo USA, Inc.
Route N/A ORAL
Marketing Status N/A Prescription